{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:06:53Z","timestamp":1793984813927,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Benign prostatic hyperplasia (BPH) is a common chronic condition among men aged 50 or older, causing voiding and obstructive lower urinary tract symptoms. Water vapor thermal therapy (WVTT) using the Rez\u016bm\u00ae system is a new minimally invasive surgical technique that is increasingly reported as a treatment for BPH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The protocol was submitted to the PROSPERO registry. We searched PubMed, Web of Science, Embase, Cochrane Library and ClinicalTrials.gov up to July 29, 2022. Quality assessment was carried out by a 20-item checklist form prepared by the Institute of Health Economics (IHE). Double arcsine transformation was performed to stabilize the variance of the original ratio. When I<jats:sup>2<\/jats:sup>\u2009&gt;\u200950%, the random effect model was used to calculate the pooled parameters. Otherwise, the fixed effect model was used. 95% confidence intervals (CIs) were calculated. A leave-one-out sensitivity analysis was performed to evaluate the impact of each study on the pooled outcomes, and finally, Egger\u2019s test was used to assess publication bias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of seven single-arm observational studies and one random controlled trial, including 1015 patients, were included. One year after WVTT, the International Prostate Symptom Score decreased by 11.37 (95% CI: -12.53, -10.21), the IPSS Quality of Life scale decreased by 2.59 (95% CI: -2.92, -2.26), the maximum urine flow rate increased by 5.26 ml\/s (95% CI: 4.53, 5.99), and the postvoid residual decreased by 13.18 ml (95% CI: -24.32, -2.03). The most common complication was dysuria, with a pooled incidence of 21% (95% CI: 14%, 29%), and the second most common complication was hematuria, with a pooled incidence of 14% (95% CI: 10%, 18%). The pooled incidence of retreatment was 3% (95% CI: 2%, 5%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>WVTT is an attractive alternative to medication or more invasive surgical procedures and can serve as first-line therapy for men with BPH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-023-01237-2","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T19:02:19Z","timestamp":1682708539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and safety of Water Vapor Thermal Therapy in the treatment of benign prostate hyperplasia: a systematic review and single-arm Meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Junyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirixiatijiang","family":"Amier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"1237_CR1","doi-asserted-by":"crossref","unstructured":"Aladesuru O, Amankwah K, Elterman D, Zorn KC, Bhojani N, Te A et al. Pilot Study of \u201cLess is More\u201d Rezum for Treatment of BPH. Urology 2022;165:256 \u2013 60.","DOI":"10.1016\/j.urology.2022.01.039"},{"key":"1237_CR2","first-page":"159","volume":"9","author":"MF Darson","year":"2017","unstructured":"Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rez\u016bm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol. 2017;9:159\u201368.","journal-title":"Res Rep Urol"},{"key":"1237_CR3","first-page":"207","volume":"8","author":"CM Dixon","year":"2016","unstructured":"Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016;8:207\u201316.","journal-title":"Res Rep Urol"},{"key":"1237_CR4","doi-asserted-by":"crossref","unstructured":"Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC, Large. Multi-Center, Prospective Registry of Rez\u016bm Water Vapor Therapy for Benign Prostatic Hyperplasia.Urology2022-1;165:261\u20137.","DOI":"10.1016\/j.urology.2022.02.001"},{"key":"1237_CR5","first-page":"699","volume":"18","author":"R Wasserbauer","year":"2021","unstructured":"Wasserbauer R, Pacik D, Varga G, Vit V, Jarkovsky J, Fedorko M. Short-term outcomes of Water Vapor Therapy (Rez\u016bm) for BPH\/LUTS in the First Czech Cohort. Urol J. 2021;18:699\u2013702.","journal-title":"Urol J"},{"key":"1237_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.acuro.2021.11.003","volume":"46","author":"E Fernandez-Guzman","year":"2022","unstructured":"Fernandez-Guzman E, Asensio Matas A, Capape Poves V, Rioja Zuazu J, Garrido Abad P, Martinez-Salamanca JI, et al. Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezum steam system. Actas Urol Esp. 2022;46:310\u20136.","journal-title":"Actas Urol Esp"},{"key":"1237_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally invasive prostate Convective Water Vapor Energy ablation: a Multicenter, Randomized, controlled study for the treatment of lower urinary tract symptoms secondary to Benign Prostatic Hyperplasia. J Urol. 2016;195:1529\u201338.","journal-title":"J Urol"},{"key":"1237_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/pros.24191","volume":"81","author":"M Ines","year":"2021","unstructured":"Ines M, Babar M, Singh S, Iqbal N, Ciatto M. Real-world evidence with the Rez\u016bm System: a retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes. Prostate. 2021;81:956\u201370.","journal-title":"Prostate"},{"key":"1237_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s40258-022-00735-y","volume":"20","author":"L Knight","year":"2022","unstructured":"Knight L, Dale M, Cleves A, Pelekanou C, Morris R. UroLift for treating lower urinary tract symptoms of Benign Prostatic Hyperplasia: a NICE Medical Technology Guidance Update. Appl Health Econ Health Policy. 2022;20:669\u201380.","journal-title":"Appl Health Econ Health Policy"},{"key":"1237_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jsxm.2016.03.372","volume":"13","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Erectile and ejaculatory function preserved with Convective Water Vapor Energy treatment of lower urinary tract symptoms secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. J Sex Med. 2016;13:924\u201333.","journal-title":"J Sex Med"},{"key":"1237_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.purol.2020.05.004","volume":"30","author":"C Alegorides","year":"2020","unstructured":"Alegorides C, Fourmarier M, Eghazarian C, Lebdai S, Chevrot A, Droupy S. Treatment of benign prostate hyperplasia using the Rezum\u00ae water vapor therapy system: results at one year. Prog Urol. 2020;30:624\u201331.","journal-title":"Prog Urol"},{"key":"1237_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","volume":"197","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Convective thermal therapy: durable 2-Year results of Randomized Controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to Benign Prostatic Hyperplasia. J Urol. 2017;197:1507\u201316.","journal-title":"J Urol"},{"key":"1237_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:1\u201313.","journal-title":"BMC Med Res Methodol"},{"key":"1237_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805.","journal-title":"Stat Methods Med Res"},{"key":"1237_CR15","unstructured":"Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z et al. Detecting the skewness of data from the sample size and the five-number summary. arXiv preprint arXiv:2010.05749 2020."},{"key":"1237_CR16","unstructured":"Moga C, Guo B, Schopflocher DP, Harstall C. Development of a quality appraisal tool for case series studies using a modified Delphi technique. 2012."},{"key":"1237_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11845-021-02552-z","volume":"191","author":"UM Haroon","year":"2022","unstructured":"Haroon UM, Khan JSA, McNicholas D, Forde JC, Davis NF, Power RE. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis. Ir J Med Sci. 2022;191:421\u20136.","journal-title":"Ir J Med Sci"},{"key":"1237_CR18","first-page":"e18083","volume":"13","author":"R Rowaiee","year":"2021","unstructured":"Rowaiee R, Akhras A, Lakshmanan J, Sikafi Z, Janahi F. Rezum Therapy for Benign Prostatic Hyperplasia: Dubai\u2019s initial experience. Cureus. 2021;13:e18083.","journal-title":"Cureus"},{"key":"1237_CR19","unstructured":"Miernik A, Gratzke C. Current Treatment for Benign Prostatic Hyperplasia. Deutsches Arzteblatt international;117:843 \u2013 54."},{"key":"1237_CR20","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1007\/s00345-020-03548-7","volume":"39","author":"EB Garden","year":"2021","unstructured":"Garden EB, Shukla D, Ravivarapu KT, Kaplan SA, Reddy AK, Small AC, et al. Rezum therapy for patients with large prostates ( > = 80\u00a0g): initial clinical experience and postoperative outcomes. World J Urol. 2021;39:3041\u20138.","journal-title":"World J Urol"},{"key":"1237_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/and.14450","author":"V Gauhar","year":"2022","unstructured":"Gauhar V, Lim EJ, Khan TY, Law YXT, Choo ZW, Castellani D, et al. Rezum to the rescue: early outcomes of Rezum on patients with recurrent lower urinary tract symptoms after surgical interventions for benign prostatic enlargement. ANDROLOGIA. 2022. https:\/\/doi.org\/10.1111\/and.14450.","journal-title":"ANDROLOGIA"},{"key":"1237_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2017.10.023","volume":"111","author":"KT McVary","year":"2018","unstructured":"McVary KT, Roehrborn CG. Three-year outcomes of the prospective, randomized controlled Rez\u016bm System Study: Convective Radiofrequency Thermal Therapy for treatment of lower urinary tract symptoms due to Benign Prostatic Hyperplasia. Urology. 2018;111:1\u20139.","journal-title":"Urology"},{"key":"1237_CR23","doi-asserted-by":"crossref","unstructured":"Kim EH, Larson JA, Andriole GL. Management of Benign Prostatic Hyperplasia. Annual review of medicine;67:137 \u2013 51.","DOI":"10.1146\/annurev-med-063014-123902"},{"key":"1237_CR24","doi-asserted-by":"crossref","unstructured":"McVary KT, El-Arabi A, Roehrborn C. Preservation of Sexual Function 5 Years After Water Vapor Thermal Ther apy for Benign Prostatic Hyperplasia. Sexual medicine;9:100454.","DOI":"10.1016\/j.esxm.2021.100454"},{"key":"1237_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.5152\/tud.2021.21128","volume":"47","author":"A Cocci","year":"2021","unstructured":"Cocci A, Bocchino AC, Cito G, Lisa A, Russo GI, Giudice AL, et al. Role of Rezum in the treatment of benign prostate hyperplasia: a review of the literature. Turk J Urol. 2021;47:452\u201360.","journal-title":"Turk J Urol"},{"key":"1237_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/luts.12435","volume":"14","author":"M Babar","year":"2022","unstructured":"Babar M, Loloi J, Tang K, Syed U, Ciatto M. Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review. Low Urin Tract Symptoms. 2022;14:140\u201354.","journal-title":"Low Urin Tract Symptoms"},{"key":"1237_CR27","doi-asserted-by":"publisher","unstructured":"Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC. Rezum therapy for > = 80-mL benign prostatic enlargement: a large, multicentre cohort study. BJU INTERNATIONAL 2022-2 DOI:https:\/\/doi.org\/10.1111\/bju.15753.","DOI":"10.1111\/bju.15753"},{"key":"1237_CR28","doi-asserted-by":"crossref","unstructured":"Spinos T, Katafigiotis I, Leotsakos I, Grivas N, Zabaftis C, Ermidis D et al. Rez\u016bm water vapor therapy for the treatment of patients with urinary r etention and permanent catheter dependence secondary to benign prostat e hyperplasia: a systematic review of the literature. World journal of urology;41:413 \u2013 20.","DOI":"10.1007\/s00345-022-04258-y"},{"key":"1237_CR29","doi-asserted-by":"crossref","unstructured":"Tadrist A, Baboudjian M, Bah MB, Alegorides C, Bottet F, Arroua F et al. Water vapor thermal therapy for indwelling urinary catheter removal in frail patients.International urology and nephrology;55:249\u201353.","DOI":"10.1007\/s11255-022-03408-w"},{"key":"1237_CR30","doi-asserted-by":"crossref","unstructured":"Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporization of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic h yperplasia: a systematic review with meta-analysis from 2002 to 2012. European urology;62:315 \u2013 23.","DOI":"10.1016\/j.eururo.2012.04.051"},{"key":"1237_CR31","doi-asserted-by":"publisher","unstructured":"Sahakyan Y, Erman A, Bhojani N, Chughtai B, Zorn KC, Sander B et al. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study. Prostate Cancer Prostatic Dis 2022 Jun 10 [Epub] DOI:https:\/\/doi.org\/10.1038\/s41391-022-00561-2.","DOI":"10.1038\/s41391-022-00561-2"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-023-01237-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-023-01237-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-023-01237-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T19:04:17Z","timestamp":1682708657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-023-01237-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1186\/s12894-023-01237-2","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a systematic review and single-arm meta-analysis, registered at the International prospective register of systematic reviews (PROSPERO, ), number CRD42022350207.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"72"}}